Equity & Investment Strategy Research

A truly comprehensive approach, with research covering global sector, regional, political and quantitative strategy including proprietary dividend models.

Contact Us for a trial.

Equity & Investment Strategy

Back

Equity & Investment Strategy Team

Jonathon Griggs
David Bowers
Managing Director & Head of Research
Ian Harnett
Managing Director & Chief Investment Strategist
Charles Cara
Head of Quantitative Strategy
Richard Mylles
Political Analyst
Aaron Thompson
Research Associate

Equity & Investment Strategy Research

Equity & Investment Strategy Products: Investment Strategy Weekly, Asset Allocation Quarterly, Politics & Themes, Surveys.

Page 1: Next  

Equity Strategy - Coronavirus Creates Testing Times for TINA
28 Feb 2020
: Ian Harnett, David Bowers

Increased concern around Coronavirus has Impacted Bond and Equities
This week has seen complacency about the impact of the Coronavirus shattered, US Treasury yields have fallen across the curve and the Global Equity sell-off has shifted from selling Cyclicals to investors focusing on selling last year’s winners.

The short term moves in Bond/Equity Yield Ratios should signal a rally
The combination of the equity sell-off and low bond yields has taken the short-term Z-Scores of the Bond / Equity Yield Ratio to levels that have previously seen investors decide that ‘There is No Alternative’ to switching back into Equities.

This is a critical point – a failure to rally here could signal major risks
Elevated volatility across Equities, Bonds and FX, as well as Bond/Equity valuations, should trigger a risk asset rally. If, however, a rally is not sustained and supply-chains are disrupted, Equity risks are substantial. We remain defensive for now.

Equity Strategy - Corporate Inequality in an Age of Divergence
20 Feb 2020
: Ian Harnett, David Bowers

Rising corporate inequality is leading to increased corporate fragility
Although Coronavirus briefly dented the rally seen since January 2019, markets are back to favouring US equities and Growth stocks. The focus on a narrow range of stocks is leading to increased corporate inequality between the winners and losers

We see more divergence in Corporate Debt, Earnings and Valuations
However, there is a risk of the US experiencing the ‘Dutch disease’ as US Tech dominance hollows-out other sectors, resulting in increased corporate fragility due to divergent trends in debt, earnings, valuations, access to capital and employment

We are monitoring potential catalysts to trigger a rotation in strategies
We expect current sector trends to continue for now. However, potential catalysts for change range from earnings disappointments in high PE stocks, to a reduction in ad-spend or disrupted supply chains as small caps falter, or higher bond yields

1.0.0.20
1.0.0.20
Investment Strategy: Concentration of US Buybacks - Overspending on Share Repurchases by 25 Biggest Buyers
13 Feb 2020
: Charles Cara

US Buybacks are Highly Concentrated in Just 25 Companies
With a current run rate of over $700bn, share buybacks are the biggest source of liquidity in the US market. Repurchases are even more concentrated than profits and Market Capitalisation and just 25 companies account for over half the total.

Profit Growth Cannot Offset Unsustainable Rise of Distributions
The US tax reform unlocked foreign earnings, but rather than invest, these 25 companies have accelerated buybacks. They now hold net debt as their holdings of cash have been drawn down, with distributions being higher than profits.

Level of Buybacks Unlikely to Recover as Cash Holdings are Falling
These stocks still have over $500bn of cash and are currently growing profits, so we do not see an imminent halt to their buybacks. However, given falling cash reserves, buybacks are unlikely to rise to the levels reached in 2019 any time soon.

Equity Strategy - Post-Brexit Catalysts for UK Equities
6 Feb 2020
: David Bowers, Richard Mylles

The UK has left the European Union: What Next?
More than three years of prolonged and chronic uncertainty has undermined UK assets. But Boris Johnson’s emphatic election victory has delivered Brexit. However, what remains to be settled is the UK’s future relationship with the EU.  

Focus to Turn towards Radical Microeconomic Change
The economic rationale for Brexit lies in a belief that the UK can create a more optimal regulatory environment than that offered by Brussels. It demands that the UK actively diverges from EU’s regulatory environment. It’s about micro not macro.

UK Equities: Undemanding Valuations in Search of a Catalyst
We think the UK faces a trade rupture next January even if there is a UK-EU Free Trade Agreement. Investors should therefore focus more on the upcoming UK Budget for signs of a commitment to radical productivity-boosting initiatives.

1.0.0.20
Equity Strategy - Challenges for Eurozone Equities: How the Backdrop for Eurozone Corporates Might Change
31 Jan 2020
: David Bowers

Eurozone Equities – Searching for Catalysts
In a week where the market capitalisation of Apple exceeded that of the DAX index, we decided to look at eurozone equities. For the first two decades, eurozone policymaking has favoured bond holders; we explore how that might change.

Investors may be Underestimating the Pace of that Change
The eurozone is (1) reviewing monetary policy; (2) revisiting fiscal activism to address climate change; (3) under pressure to change the fiscal - monetary policy mix; (4) facing its own Brexit shock; (5) vulnerable to US-China rivalry

These Drivers may not Kick in until Next Year; France a Beneficiary
These are medium-term drivers which may not start to kick in until next year. But they should present investment opportunities. The knee-jerk reaction suggests that France ought to be a major beneficiary; but equity valuations look too rich for now.

1.0.0.20
Page 1: Next  

Click here to read our research disclaimer.

Research Disclaimer

This research report is issued by Absolute Strategy Research Ltd, which is authorised and regulated by the Financial Conduct Authority (“FCA”). Absolute Strategy Research Services Inc. is registered as an investment adviser with the US SEC, and is responsible for all communications and dealings with, and only with, US persons. The report is intended only for investors who are Eligible Counterparties or Professional Clients, as defined by MIFID and the FCA, and may not be distributed to Retail Clients.

Absolute Strategy Research Ltd does not solicit any action based upon this report, which is not to be construed as an invitation to buy or sell any security.

This report is not intended to provide personal investment advice and it does not take into account the investment objectives, financial situation and the particular needs of any particular person who may read this report.

This research report provides general information only. The information contained was obtained from sources that we believe to be reliable but we do not guarantee that it is accurate or complete, and it should not be relied upon as such. Opinions expressed are our current opinions as of the original publication date appearing on this material only and the information, including the opinions contained herein, are subject to change without notice.

This research report may not be redistributed, retransmitted or disclosed in whole or in part, without the express written permission of Absolute Strategy Research Ltd.

© Absolute Strategy Research Ltd 2016. All rights reserved.

Absolute Strategy Research Ltd. 1-2 Royal Exchange Buildings, London, EC3V 3LF. Phone: +44 (0) 20 7073 0730 Fax: +44 (0) 20 7073 0732. www.absolutestrategy.com.

Absolute Strategy Research Ltd is registered in England and Wales. Company number 5727405. Registered Office: Salisbury House, Station Road, Cambridge CB1 2LA.

Close